Pharmaceutical Executive June 4, 2024
Mike Hollan

BD announced that it will pay cash to acquire the advanced monitoring solutions company.

Medical technology company Becton, Dickinson, and Company (BD) announced that it will acquire Edwards Lifesciences’ Critical Care Product Group for $4.2 billion in cash. According to a press release,1 BD acquired the advanced monitoring solutions company in order to expand its own smart connected care solutions.

The acquisition is expected to close by the end of 2024. In order to fund it, BD will use about $1 billion of its own cash and take on $3.2 billion of new debt. Within a year to a year-and-a-half from closing, BD plans on significantly reducing its debt load by deploying free cash flows towards repayment.

In a press...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
The capital required for AI-enabled medical devices
Miist Therapeutics Raises $7M to Develop Inhaled Medicines with Physics-Based Approach
70% of People with Diabetes Feel Stigma: Abbott Survey Reveals Challenges
OCT Medical Devices 2025: AI’s value appreciable, yet human touch remains key
GE HealthCare invests $138M in new contrast media manufacturing site amid rising demand

Share This Article